Effect of α-phenyl-N-tert-butylnitrone on diabetes and lipid peroxidation in BB rats

Canadian Journal of Physiology and Pharmacology

Volumn 77, Issue 3, 1999, Pages 166-174

  Iovino, Giugetta ^a,b   Kubow, Stan ^b   Marliss, Errol B ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

phenyl N tert butylnitrone; BB rats; Lipid peroxidation; Malondialdehyde; Spin traps; Type 1 diabetes mellitus

Indexed keywords

N TERT BUTYL ALPHA PHENYLNITRONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; GLUCOSE TOLERANCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE TOLERANCE TEST; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITROGEN OXIDES; PANCREAS; RATS; RATS, INBRED BB; SPIN LABELS;

EID: 0032810629     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-77-3-166     Document Type: Article

References (64)

1. Bolli, R., Patel, B.S., Jeroudi, M.O., Lai, E.K., and McCay, P.B. 1988. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of spin trap N-tert-butyl nitrone. J. Clin. Invest. 82: 476-485.
2. Brackett, D.J., Lai, E.K., Lerner, M.R., Wilson, M.F., and McCay, P.B. 1989. Spin trapping of free radicals produced in vivo in heart and liver during endotoxemia. Free Radical Res. Commun. 7: 315-324.
3. Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Landum, R.W., Cheng, M.S., Wu, J.F., and Floyd, R.A. 1991. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 68: 3633-3636.
4. Chen, G.M., Bray, T.M., Janzen, E.G., and McCay, P.B. 1990. Excretion, metabolism and tissue distribution of a spin trapping agent, α-phenyl-N-tert-butyl-nitrone (PBN) in rats. Free Radical Res. Commun. 9: 317-323.
5. Clough-Helfman, C., and Phillis, J.W. 1991. The free radical trapping agent N-tert-butyl-α-phenylnitrone (PBN) attenuates cerebral ischemic injury in gerbils. Free Radical Res. Commun. 15: 177-186.
6. Corbett, J.A., and McDaniel, M.L. 1992. Does nitric oxide mediate autoimmune destruction of B-cells? Diabetes, 41: 897-890.
7. Drash, A.L., Rudert, W.A., Borquaye, S., Wang, R., and Leiberman, U.I. 1988. Effect of probucol on development of diabetes mellitus in BB rats. Am. J. Cardiol. 62: 27B-30B.
8. Edamatsu, R., Mori, A., and Packer, L. 1995. The spin-trap N-tert-α-phenyl-butylnitrone prolongs the life span of the senescence accelerated mouse. Biochem. Biophys. Res. Commun. 211: 847-849.
9. Esterbauer, H., Schaur, R.J., and Zollner, H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biol. Med. 11: 81-129.
10. Faust, A., Burkart, V., Ulrich, H., Weischer, C.H., and Kolb, H. 1994. Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice. Int. J. Immunopharmacol. 16: 61-66.
11. Flechner, I., Maruta, K., Burkart, V., Kawai, K., Kolb, H., and Kiesel, U. 1990. Effects of radical scavengers on the development of experimental diabetes. Diabetes Res. 13: 67-71.
12. Fukuda, M., Ikegami, H., Kawaguchi, Y., Sano, T., and Ogihara, T. 1995. Antioxidant, probucol, can inhibit the generation of hydrogen peroxide in islet cells induced by macrophages and prevent islet cell destruction in NOD mice. Biochem. Biophys. Res. Commun. 209: 953-958.
13. Fukunaga, K., Takama, K., and Suzuki, T. 1993a. High-performance liquid chromatographic determination of plasma malondialdehyde level without a solvent extraction procedure. Anal. Biochem. 230: 20-23.
14. Fukunaga, K., Suzuki, T., and Takama, K. 1993b. Highly sensitive high-performance liquid chromatography for the measurement of malondialdehyde in biological samples. J. Chromatogr. 621: 77-81.
15. Gould, T.J., and Bickford, P.C. 1994. The effects of chronic treatment with N-tert-butyl-α-phenylnitrone on cerebellar noradrenergic receptor function in aged F344 rats. Brain Res. 660: 333-336.
16. Hall, N.C., Carney, J.M., Cheng, M., and Butterfield, D.A. 1995. Prevention of ischemia reperfusion-induced alterations in synaptosomal membrane-associated proteins and lipids by N-tert-butyl-α-phenylnitrone and difluoromethylornithine. Neuroscience, 69: 591-600.
17. Halliwell, B., and Gutteridge, J.M.C. 1989. Free radicals in biology and medicine. Clarendon, Oxford, England.
18. Hayward, A.R., Schriber, M., and Sokol, R. 1992. Vitamin E supplementation reduces the incidence of diabetes but not insulitis in NOD mice. J. Lab. Clin. Med. 119: 503-507.
19. Heineke, E.W., Johnson, M.B., Dillberger, J.E., and Robinson, K.M. 1993. Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice. Diabetes, 42: 1721-1730.
20. Janero, D.R. 1990. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol. Med. 9: 515-540.
21. Joseph, J.A., Cao, G., and Cutler, R.C. 1995. In vivo or in vitro administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone (PBN) reduces age-related deficits in striatalmuscarinic receptor sensitivity. Brain Res. 671: 73-77.
22. Jotti, A., Paracchini, L., Perletti, G., and Piccinini, F. 1992. Cardiotoxicity induced by doxorubicin in vivo: protective activity of the spin trap α-phenyl N-tert-butylnitrone. Pharmacol. Res. 26: 143-150.
23. Kolb, H., and Kolb-Bachofen, V. 1992. Nitric oxide: a pathogenic factor in autoimmunity. Immunol. Today, 18: 157-160.
24. Kunert, K.-J., and Tappel, A.L. 1983. The effect of vitamin C on in vivo lipid peroxidation in guinea pigs as measured by petane and ethane production. Lipids, 18: 271-274.
25. Lai, E.K., Crossley, C., Sridhar, R., Mira, H.P., Janzen, E.G., and McCay, P.B. 1986. In vivo spin trapping of free radicals generated in brain, spleen and liver during gamma-radiation in mice. Arch. Biochem. Biophys. 244: 156-160.
26. Le Guen, C.A., Jones, A.F., Barnett, A.H., and Lunec, J. 1992. Role of reactive oxygen species in the generation of fluorescence by glycation. Ann. Clin. Biochem. 29: 184-189.
27. Mandrup-Poulsen, T., Helqvist, S., Wogensen, L.D., Molvig, J., Pociot, F., Johannesen, J., and Nerup, J. 1989. Cytokines and free radicals as effector molecules in the destuction of pancreatic beta cells. Curr. Top. Microbiol. Immunol. 164: 169-193.
28. Markholst, H., and Lernmark, A. 1988. Reduced pancreatic insulin is associated with retarded growth of the pancreas in young prediabetic BB rats. Pancreas, 32: 140-144.
29. Marliss, E.B., Nakhooda, A.F., Poussier, P., and Sima, A.A. 1982. The diabetic syndrome of the 'BB' Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia, 22: 225-232.
30. Matsushita, M., Yashino, G., Iwai, M., Matsuba, K., Morita, M., Iwatani, I., Yoshida, M., Kazumi, T., and Baba, S. 1989. Protective effect of probucol on alloxan diabetes in rats. Diabetes Res. Clin. Pract. 7: 313-316.
31. McCay, P.B., Lai, E.K., Poyer, J.L., Dubose, C.M., and Janzen, E.G. 1984. Oxygen- and carbon-centered free radical formation during carbon tetrachloride metabolism. Observation of lipid radicals in vivo and in vitro. J. Biol. Chem. 259: 2135-2143.
32. Mendola, J., Wright, J.R., and Lacy, P.E. 1989. Oxygen free radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozotocin-induced insulitis. Diabetes, 38: 379-385.
33. Misra, M., Duguid, W.P., and Marliss, E.B. 1996. Prevention of diabetes in the spontaneously diabetic BB rat by the glutamine antimetabolite acivicin. Can. J. Physiol. Pharmacol. 74: 163-172.
34. Murthy, V.K., Shipp, J.C., Hanson, C., and Shipp, D.M. 1992. Delayed onset and decreased incidence of diabetes in BB rats fed free radical scavengers. Diabetes Res. Clin. Pract. 18: 11-16.
35. Nakhooda, A.F., Poussier, P., and Marliss, E.B. 1983. Insulin and glucagon secretion in BB Wistar rats with impaired glucose tolerance. Diabetologia, 24: 58-62.
36. Nomikos, I.N., Prowse, S.J., Carotenuto, P., and Lafferty, K.J. 1986. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes, 35: 1302-1304.
37. 2 radicals in autoimmune diabetes. Immunol. Cell. Biol. 67: 85-87.
38. Novelli, G.P. 1992. Oxygen radicals in experimental shock: effects of spin-trapping nitrones in ameliorating shock pathophysiology. Crit. Care. Med. 20: 499-507.
39. Oliver, C.N., Starke-Reed, P.E., Stadtman, E.R., Liu, G.J., Carney, J.M., and Floyd, R.A. 1990. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. U.S.A. 87: 5144-5147.
40. Papaccio, G., Esposito, V., Pisanti, F.A., and Frascatore, S. 1986. Acetyl-homocysteine-thiolactone-induced increase of superoxide dismutase counteracts the effect of subdiabetogenic doses of streptozotocin. Diabetes, 35: 470-474.
41. Paracchini, L., Jotti, A., Bottiroli, G., Prosperi, E., Supino, R., and Piccinini, F. 1993. The spin trap α-phenyl-tert-butyl nitrone protects against myelotoxicity and cardiotoxicity of adriamycin while preserving the cytotoxic activity. Anticancer Res. 13: 1607-1612.
42. Phillis, J.W., and Clough-Helfman, C. 1990. Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-α-phenylnitrone (PBN). Neurosci. Lett. 116: 315-319.
43. Pogrebniak, H., Merino, M.J., Hahn, M., Mitchell, J.B., and Pass, H.I. 1992. Spin trap salvage from endotoxemia: the role of cytokine down-regulation. Surgery, 112: 130-139.
44. Rabinovitch, A. 1992. Free radicals as mediators of pancreatic islet B-cell injury in autoimmune diabetes. J. Lab. Clin. Med. 119: 455-456.
45. Rabinovitch, A., Suarez-Pinzon, W.L., and Power, R.F. 1992. Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in NOD mice. Life Sci. 51: 1937-1943.
46. Rabinovitch, A., Suarez, W.L., and Power, R.F. 1993. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice. J. Lab. Clin. Med. 121: 603-607.
47. Reddy, S., Bibby, N.J., and Elliott, B. 1990. Early nicotinamide treatment in the NOD mouse: effects on diabetes and insulitis suppression and antibody levels. Diabetes Res. 15: 95-102.
48. Rice-Evans, C., and Burdon, R. 1993. Free radical - lipid interactions and their pathological consequences. Prog. Lipid Res. 32: 71-110.
49. Rossini, A.A., Mordes, J.P., Gallina, I.D., and Like, A.A. 1983. Hormonal and environmental factors in the pathogenesis of BB rat diabetes. Metabolism, 32 (Suppl. 1): 33-36.
50. Roza, A.M., Slakey, D.P., Pieper, G.M., Van Ye, T.M., Moore- Hilton, G., Komorowski, R.A., Johnson, C.P., Hedlund, B.E., and Adams, M.B. 1994. Hydroxyethyl starch deferoxamine, a novel iron chelator, delays diabetes in BB rats. J. Lab. Clin. Med. 123: 556-560.
51. Rungby, J., Flyvjerg, A., and Andersen, H.B. 1992. Lipid peroxidation in early experimental diabetes in rats: effects of diabetes and insulin. Acta Endocrinol. 126: 378-380.
52. Sarri, Y., Mendola, J., Ferrer, J., and Gomis, R. 1989. Preventive effects of nicotinamide administration on spontaneous diabetes of BB rats. Med. Sci. Res. 17: 987-988.
53. Schulz, J.B., Henshaw, D.R., Siwek, D., Jenkins, B.G., Ferrante, R.J., Cipolloni, P.B., Kowall, N.W., Rosen, B.R., and Beal, M.F. 1995. Involvement of free radicals in cytotoxicity in vivo. J. Neurochem. 64: 2239-2247.
54. Sen, S., and Phillis, J.W. 1993. α-Phenyl-tert-butyl-nitrone (PBN) attenuates hydroxyl radical production during ischemia-reperfusion injury of rat brain: an EPR study. Free Radical Res. Commun. 19: 255-265.
55. Sen, S., Goldman, H., Morehead, M., Murphy, S., and Phyllis, W. 1994. α-Phenyl-tert-butyl-nitrone inhibits free radical release in brain concussion. Free Radical Biol. Med. 16: 685-691.
56. Slonim, A.E., Surber, M.L., Page, D.L., Sharp, R.A., and Burr, I.M. 1983. Modification of chemically induced diabetes in rats by vitamin E. J. Clin. Invest. 71: 1282-1288.
57. 4 induced hepatotoxicity in rats. Free Radical Biol. Med. 14: 677-681.
58. Uehara, Y., Shimizu, H., Sato, N., Shimura, Y., Mori, M., and Kobayashi, I. 1991. Probucol partially prevents development of diabetes in NOD mice. Diabetes Res. 17: 131-134.
59. Vlahos, W.D., Seemayer, T.A., and Yale, J.F. 1991. Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism, 40: 825-829.
60. Yale, J.F., Roy, R.D., Grose, M., Seemayer, T.A., Murphy, J., and Marliss, E.B. 1985. Effects of cyclosporine on glucose tolerance in the rat. Diabetes, 34: 1309-1313.
61. Yamada, K., Nonaka, K., Hanafusa, T., Miyazaki, A., Toyoshima, H., and Tarui, S. 1982. Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis: an observation in nonobese diabetic (NOD) mice. Diabetes, 31: 751-753.
62. Yamashita, T., Oshima, H., Asanuma, T., Inukai, N., Miyoshi, I., Kasai, N., Kon Y., Watanabe, T., Sato, F., and Kuwabara, M. 1996. The effects of alpha-phenyl-tert-butyl nitrone (PBN) on copper-induced rat fulminant hepatitis with jaundice. Free Radical Biol. Med. 21: 755-761.
63. Young, I.S., Torney, J.J., and Trimble, E.R. 1992. The effects of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Radical Biol. Med. 13: 41-46.
64. Yue, T.L., Gu, J.L., Lysko, P.G., Chen, H.Y., Barone, F.C., and Feuerstein, G. 1992. Neuroprotective effect of phenyl-t-butylnitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res. 574: 193-197.